ATE522813T1 - Verfahren für den nachweis karzinomatöser epithelzellen mittels freigesetzter zytokeratine als marker für diese zellen - Google Patents
Verfahren für den nachweis karzinomatöser epithelzellen mittels freigesetzter zytokeratine als marker für diese zellenInfo
- Publication number
- ATE522813T1 ATE522813T1 AT07825055T AT07825055T ATE522813T1 AT E522813 T1 ATE522813 T1 AT E522813T1 AT 07825055 T AT07825055 T AT 07825055T AT 07825055 T AT07825055 T AT 07825055T AT E522813 T1 ATE522813 T1 AT E522813T1
- Authority
- AT
- Austria
- Prior art keywords
- cells
- marker
- released
- detecting
- cytokeratins
- Prior art date
Links
- 239000003550 marker Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 5
- 210000004027 cell Anatomy 0.000 title abstract 4
- 210000002919 epithelial cell Anatomy 0.000 title abstract 4
- 102000011782 Keratins Human genes 0.000 abstract 1
- 108010076876 Keratins Proteins 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84290206P | 2006-09-07 | 2006-09-07 | |
| PCT/IB2007/002549 WO2008029251A2 (en) | 2006-09-07 | 2007-09-04 | Method for the detection of cancerous epithelial cells using released cytokeratins as markers for said cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE522813T1 true ATE522813T1 (de) | 2011-09-15 |
Family
ID=39027595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07825055T ATE522813T1 (de) | 2006-09-07 | 2007-09-04 | Verfahren für den nachweis karzinomatöser epithelzellen mittels freigesetzter zytokeratine als marker für diese zellen |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8524493B2 (de) |
| EP (1) | EP2064552B1 (de) |
| AT (1) | ATE522813T1 (de) |
| ES (1) | ES2375453T3 (de) |
| WO (1) | WO2008029251A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0815675D0 (en) | 2008-08-28 | 2008-10-08 | Mabtech Ab | Antibody secreting cell elispot |
| US9535065B2 (en) | 2011-09-06 | 2017-01-03 | Becton, Dickinson And Company | Methods and compositions for cytometric detection of rare target cells in a sample |
| JP6352909B2 (ja) | 2012-06-27 | 2018-07-04 | バーグ エルエルシー | 前立腺癌の診断および処置におけるマーカーの使用 |
| US10539566B2 (en) | 2014-12-08 | 2020-01-21 | Berg Llc | Use of markers including filamin A in the diagnosis and treatment of prostate cancer |
| LU500787B1 (en) | 2021-10-26 | 2023-04-27 | Univ Hamburg Eppendorf Uke | Isolation and detection of cdcp1 positive circulating tumor cells |
| LU501430B1 (en) | 2022-02-09 | 2023-08-09 | Univ Hamburg Eppendorf Uke | Enrichment, detection and characterization of circulating tumor cells with susd2 and enpp1 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1985003132A1 (en) | 1984-01-06 | 1985-07-18 | The Regents Of The University Of California | Cytokeratin tumor markers and assays for their detection |
| DE3942999C2 (de) * | 1989-12-27 | 1997-12-18 | Progen Biotechnik Gmbh | Verfahren zum Nachweis von malignen Erkrankungen |
| EP2230320B1 (de) * | 2000-03-27 | 2015-07-01 | Thomas Jefferson University | Zusammensetzung zur Behandlung und Visualisierung von Magen- und Speiseröhren-Krebszellen |
| ATE331958T1 (de) | 2002-03-13 | 2006-07-15 | Biomerieux Sa | Verfahren zum nachweis und zur quantifizierung von -aus soliden tumoren abstammenden- zirkulierenden tumorzellen |
| CA2498783A1 (en) * | 2002-09-12 | 2004-03-25 | Yissum Research Development Company Of The Hebrew University Of Jerusale M | Method for detection of micro-metastasis |
-
2007
- 2007-09-04 US US12/439,744 patent/US8524493B2/en active Active
- 2007-09-04 EP EP07825055A patent/EP2064552B1/de active Active
- 2007-09-04 AT AT07825055T patent/ATE522813T1/de active
- 2007-09-04 WO PCT/IB2007/002549 patent/WO2008029251A2/en active Application Filing
- 2007-09-04 ES ES07825055T patent/ES2375453T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US8524493B2 (en) | 2013-09-03 |
| WO2008029251A3 (en) | 2008-05-22 |
| WO2008029251A2 (en) | 2008-03-13 |
| ES2375453T3 (es) | 2012-03-01 |
| EP2064552A2 (de) | 2009-06-03 |
| EP2064552B1 (de) | 2011-08-31 |
| US20100184083A1 (en) | 2010-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE455871T1 (de) | Verfahren und substanzen zur isolierung von mirnas | |
| ATE522813T1 (de) | Verfahren für den nachweis karzinomatöser epithelzellen mittels freigesetzter zytokeratine als marker für diese zellen | |
| EA201600085A1 (ru) | Набор для обнаружения соевого события syht0h2 | |
| EA025172B9 (ru) | Способ оценки способности достижения одним или более эмбрионами человека стадии бластоцисты | |
| ATE517192T1 (de) | Verfahren zur isolierung von zellen | |
| MX2011004169A (es) | Metodos para la separacion y caracterizacion de microorganismos utilizando agentes identificadores. | |
| ATE552505T1 (de) | Quantifizierbare interne referenzstandards für immunhistochemie und verwendung | |
| DE602006002809D1 (de) | Verfahren zur erkennung eines ovarialkarzinoms | |
| IN2014CN01970A (de) | ||
| MX2013004172A (es) | Metodos y kits para la deteccion de células tumorales circulantes en pacientes pancreáticos por medio del uso de captura poliespecífica y reactivos de detección de cocteles. | |
| DK2132339T3 (da) | Fremgangsmåde til detektering af en analyt i en biologisk matrix | |
| EA201390638A8 (ru) | Обогащение и идентификация фетальных клеток в материнской крови и лиганды для такого применения | |
| ATE503846T1 (de) | Verfahren zur diagnose eines ovarialkarzinoms | |
| MX2007002908A (es) | Sondas inmovilizadas y metodos para detectar proteinas prionicas alteradas conformacionalmente. | |
| ATE550645T1 (de) | Verfahren zur zerstörungsfreien prüfung von rohren | |
| GB201207297D0 (en) | Analytical methods and arrays for use in the same | |
| IN2014DN08957A (de) | ||
| ATE501166T1 (de) | Isotopenmarkiertes einfangmittel und verfahren zur identifizierung reaktiver metaboliten | |
| MX2008013397A (es) | Analisis de perfilamiento de expresion diferencial de fenotipos de cultivo celular y usos de los mismos. | |
| MX357429B (es) | Predictores para el tratamiento del cáncer. | |
| DE502006002073D1 (de) | Verfahren zur verhinderung der zeitabhängigen rna-expression in biologischen zellen | |
| ATE526583T1 (de) | Immunomagnetische erfassung und abbildung biologischer zielmoleküle | |
| WO2008073895A3 (en) | Methods and devices for testing saliva | |
| MX371379B (es) | Deteccion de la actividad de corte de una enzima. | |
| ATE529738T1 (de) | Verfahren zur zerstörungsfreien prüfung von rohren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 2064552 Country of ref document: EP |